These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 23204031
1. Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomas. Pekmezci M, Szpaderska A, Osipo C, Erşahin Ç. Int J Surg Pathol; 2013 Apr; 21(2):126-32. PubMed ID: 23204031 [Abstract] [Full Text] [Related]
5. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia. Arafah M. Turk Patoloji Derg; 2012 Apr; 28(1):38-43. PubMed ID: 22207430 [Abstract] [Full Text] [Related]
6. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients. Singh K, Wang Y, Marketkar S, Kalife ET, Steinhoff MM. Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730 [Abstract] [Full Text] [Related]
7. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM. Histopathology; 2009 Sep; 55(3):346-52. PubMed ID: 19723150 [Abstract] [Full Text] [Related]
8. Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma. East EG, Pang JC, Kidwell KM, Jorns JM. Am J Clin Pathol; 2015 Dec; 144(6):952-9. PubMed ID: 26573003 [Abstract] [Full Text] [Related]
9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N. Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [Abstract] [Full Text] [Related]
15. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y. Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [Abstract] [Full Text] [Related]
16. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA, Badiaga Y, Dembélé BK, Bagayogo DC, Diallo YL, Koné AA, Callard P, Bernaudin JF, Diallo DA. Oncology; 2012 May; 83(5):257-63. PubMed ID: 22964749 [Abstract] [Full Text] [Related]
19. Oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer: a 9-year study at Princess Noorah Oncology Center, Saudi Arabia. Satti MB. Histopathology; 2011 Sep; 59(3):537-42. PubMed ID: 21668473 [Abstract] [Full Text] [Related]
20. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P. Breast J; 2005 Sep; 11(4):278-80. PubMed ID: 15982396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]